[Treatment of inflammatory adnexal diseases with oxyphenbutazone-prednisolone].
D000236:Adenoma / Q000188:drug therapy; D000284:Administration, Oral; D000290:Adnexa Uteri; D000328:Adult; D001317:Austria; D005260:Female; D006801:Humans; D007273:Injections, Intramuscular; D010113:Oxyphenbutazone / Q000008:administration & dosage*; D000292:Pelvic Inflammatory Disease / Q000188:drug therapy*; D010406:Penicillins / Q000008:administration & dosage; D011239:Prednisolone / Q000008:administration & dosage*; D013307:Streptomycin / Q000008:administration & dosage; D013997:Time Factors; D014594:Uterine Neoplasms / Q000188:drug therapy
D010406:Penicillins; D011239:Prednisolone; D010113:Oxyphenbutazone; D013307:Streptomycin
Behandlung entzündlicher Adnexerkrankungen mit Oxyphenbutazon-Prednisolon.